SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-24-048264
Filing Date
2024-04-25
Accepted
2024-04-25 16:01:23
Documents
16
Period of Report
2024-06-12

Document Format Files

Seq Description Document Type Size
1 DEF 14A alec-20240419.htm   iXBRL DEF 14A 1903907
2 GRAPHIC img44798832_0.jpg GRAPHIC 110934
3 GRAPHIC img44798832_1.jpg GRAPHIC 665486
4 GRAPHIC img44798832_2.jpg GRAPHIC 985591
5 GRAPHIC img44798832_3.jpg GRAPHIC 720000
6 GRAPHIC img44798832_4.jpg GRAPHIC 321974
  Complete submission text file 0000950170-24-048264.txt   9353451

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT alec-20240419.xsd EX-101.SCH 27003
19 EXTRACTED XBRL INSTANCE DOCUMENT alec-20240419_htm.xml XML 284966
Mailing Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080 415-231-5660
Alector, Inc. (Filer) CIK: 0001653087 (see all company filings)

IRS No.: 822933343 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38792 | Film No.: 24876043
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)